Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.
Drube J, Ernst T, Pfirrmann M, Albert BV, Drube S, Reich D, Kresinsky A, Halfter K, Sorio C, Fabisch C, Hochhaus A, Böhmer FD. Drube J, et al. Among authors: bohmer fd. Oncotarget. 2018 Jan 15;9(10):9442-9455. doi: 10.18632/oncotarget.24253. eCollection 2018 Feb 6. Oncotarget. 2018. PMID: 29507701 Free PMC article.
SHP1 regulates a STAT6-ITGB3 axis in FLT3ITD-positive AML cells.
Reich D, Kresinsky A, Müller JP, Bauer R, Kallenbach J, Schnoeder TM, Heidel FH, Fässler R, Mann M, Böhmer FD, Jayavelu AK. Reich D, et al. Among authors: bohmer fd. Leukemia. 2020 May;34(5):1444-1449. doi: 10.1038/s41375-019-0676-5. Epub 2019 Dec 13. Leukemia. 2020. PMID: 31836852 No abstract available.
Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
Demircan MB, Schnoeder TM, Mgbecheta PC, Schröder K, Böhmer FD, Heidel FH. Demircan MB, et al. Among authors: bohmer fd. J Cancer Res Clin Oncol. 2022 Aug;148(8):1983-1990. doi: 10.1007/s00432-022-03986-3. Epub 2022 Mar 29. J Cancer Res Clin Oncol. 2022. PMID: 35348887 Free PMC article.
Cell transformation by FLT3 ITD in acute myeloid leukemia involves oxidative inactivation of the tumor suppressor protein-tyrosine phosphatase DEP-1/ PTPRJ.
Godfrey R, Arora D, Bauer R, Stopp S, Müller JP, Heinrich T, Böhmer SA, Dagnell M, Schnetzke U, Scholl S, Östman A, Böhmer FD. Godfrey R, et al. Among authors: bohmer sa, bohmer fd. Blood. 2012 May 10;119(19):4499-511. doi: 10.1182/blood-2011-02-336446. Epub 2012 Mar 20. Blood. 2012. PMID: 22438257 Free article.
Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression.
Arora D, Köthe S, van den Eijnden M, Hooft van Huijsduijnen R, Heidel F, Fischer T, Scholl S, Tölle B, Böhmer SA, Lennartsson J, Isken F, Müller-Tidow C, Böhmer FD. Arora D, et al. Among authors: bohmer sa, bohmer fd. Cell Commun Signal. 2012 Jul 11;10(1):19. doi: 10.1186/1478-811X-10-19. Cell Commun Signal. 2012. PMID: 22784513 Free PMC article.
Protein-tyrosine phosphatase DEP-1 controls receptor tyrosine kinase FLT3 signaling.
Arora D, Stopp S, Böhmer SA, Schons J, Godfrey R, Masson K, Razumovskaya E, Rönnstrand L, Tänzer S, Bauer R, Böhmer FD, Müller JP. Arora D, et al. Among authors: bohmer sa, bohmer fd. J Biol Chem. 2011 Apr 1;286(13):10918-29. doi: 10.1074/jbc.M110.205021. Epub 2011 Jan 24. J Biol Chem. 2011. PMID: 21262971 Free PMC article.
161 results